Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer
about
Antiproliferative Fate of the Tetraploid Formed after Mitotic Slippage and Its Promotion; A Novel Target for Cancer Therapy Based on Microtubule PoisonsMolecular Targeted Therapies of Aggressive Thyroid CancerAurora kinases in head and neck cancerRe-purposing clinical kinase inhibitors to enhance chemosensitivity by overriding checkpointsUpdate: the status of clinical trials with kinase inhibitors in thyroid cancerLenvatinib enhances the antitumor effects of paclitaxel in anaplastic thyroid cancerA new aurora in anaplastic thyroid cancer therapy.Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer.New therapies for dedifferentiated papillary thyroid cancerSingle agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer.Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.Promotion of mitotic catastrophe via activation of PTEN by paclitaxel with supplement of mulberry water extract in bladder cancer cellsCarfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancerUpdate on the molecular diagnosis and targeted therapy of thyroid cancer.Current status of clinical trials in head and neck cancer 2014.Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.Aurora B expression modulates paclitaxel response in non-small cell lung cancer.JD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivo.Evolving molecularly targeted therapies for advanced-stage thyroid cancers.Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.Targeted Therapies in Thyroid Cancer: An Extensive Review of the Literature.Network modeling of kinase inhibitor polypharmacology reveals pathways targeted in chemical screens.Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors.Meta-analysis of microarray datasets identify several chromosome segregation-related cancer/testis genes potentially contributing to anaplastic thyroid carcinoma
P2860
Q26746973-3BE71D9D-BFDA-4D09-A8BD-073283383276Q26774734-C6677649-5D8F-49DC-89A8-A73B7D2CE048Q28654389-2DD5FD50-ACFF-4E9C-AD71-B99411086E41Q30584974-10B91B31-FB63-4D37-8BB5-95DE133165D3Q33570056-3AA197D8-05C9-4F35-B894-36A0599BE911Q33622678-26BA9186-3674-430D-8C04-9E2CE3394F60Q33930368-D06379D8-D925-4BE8-B45E-F0C1B410C632Q34152070-2034983B-A8E2-4DBF-845C-CC322D48CC46Q35381593-494FFD65-5EEF-421C-BC66-86DBA254B1C0Q35589535-3CB41248-6902-4ECD-A361-D7E118E96F04Q35622067-33EF62FF-FF60-42F5-BF31-8F0A27458A76Q36536262-7CB793AD-1A63-4874-B29B-22E73F68ED87Q37086070-7105E5DD-68A6-4F8E-ABBD-A70FF7ACCD4EQ38208701-28808857-0D54-49B3-B1BD-A18AE26DAAA8Q38326230-DDBC9468-1A06-4ACB-9EC9-8D59E2716AAAQ38657760-AFAE5097-239D-432E-9689-6401E938BE74Q38720934-263623B3-8674-413A-A3BA-B55B4DB610B6Q38736541-30792EAE-D6D6-4E14-9E7C-E123B3426DFDQ38754489-D2D8E427-452A-4FAE-B8A3-3E1C5FA63ED2Q38798863-B1759B78-3C92-403C-9F4A-50173829C984Q38883187-9FFC74AC-E913-45C9-8F40-E4F71D29D9B9Q42375686-1309F95C-B3BF-448C-B7C0-F4B81CBFB3A7Q52685048-610C6083-23E2-47D8-B987-A4810BCBD4ECQ58569105-F99B0A16-62DB-48BC-9FD6-9366AB66A8D9
P2860
Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer
@en
Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer.
@nl
type
label
Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer
@en
Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer.
@nl
prefLabel
Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer
@en
Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer.
@nl
P2093
P2860
P1476
Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer
@en
P2093
Ayoko R Bossou
Crescent R Isham
Eric J Sherman
John A Copland
Keith C Bible
Kelly E Fisher
Laura Marlow
Rakesh Kumar
Robert C Smallridge
Vera J Suman
P2860
P304
P356
10.1126/SCITRANSLMED.3004358
P407
P577
2013-01-01T00:00:00Z